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 Tissue engineered skeletal muscle plays an important role not only in the field of 
regenerative medicine, but also in emerging areas such as soft robotics, organ-on-a-chip models 
of disease, and drug testing. However, further expansion of the applications of tissue engineered 
skeletal muscle models will require a suitable method for their long-term storage and shipment. 
Cryopreservation has long been the standard for long-term cell storage, but when it comes to the 
freezing of 3D tissues, many complications arise due to heat and mass transfer limitations. Here, 
we use a tissue engineered skeletal muscle bioactuator as a model to characterize the effects of 
freezing on skeletal muscle viability, gene expression, myotube structure, and force generation. 
We optimize the freezing medium composition and compare the effects of freezing on both 
undifferentiated and differentiated engineered skeletal muscle tissue constructs. We report an 
optimized protocol of freezing skeletal muscle constructs while undifferentiated, which not only 
maintains cell viability, but leads to a 3-fold increase in force production as compared to unfrozen 
muscle. The reported timeline for skeletal muscle tissue fabrication, freezing, and revival not only 
promotes a more streamlined fabrication process, but will further enable collaborative research 
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CHAPTER 1: INTRODUCTION 
 
Engineered skeletal muscle tissue has long been of interest to the tissue engineering 
community, because of its potential to counteract loss of function resulting from volumetric muscle 
loss injuries or degenerative illness [1], [2]. More recently, efforts to tissue engineer skeletal 
muscle have targeted applications beyond regenerative medicine, such as organ-on-a-chip models 
of disease [3]–[5], formation of in vitro neuromuscular junctions [6], [7], and cell-based 
bioactuators for soft robotics [8]–[11]. As these studies generate more functional tissues, with 
different end use applications, there is a growing need for a robust method of storing engineered 
skeletal muscle long-term.  
Cryopreservation has long been the standard for storing living cells that must be revived 
post-preservation [12]. While cryopreservation of cell suspensions is a well understood and 
characterized process, freezing and revival of engineered tissue has not been investigated or 
optimized with similar rigor, as the protocol must be customized to tissue type [13]. Most cell 
freezing processes rely on the use of dimethyl sulfoxide (DMSO), a cryoprotectant that inhibits 
the formation of ice crystals that could lyse cells, in the freezing medium [14]. However, it is 
unclear whether this medium composition is sufficient for preserving the morphology and function 
of myoblasts embedded within 3D engineered skeletal muscle tissue. Since this has not been 
reported in the literature, to our knowledge, there is a need for the growing body of skeletal muscle 
tissue engineers to understand, optimize, and use a standardized protocol for long-term storage and 
revival of the tissue.  
Engineering mature contractile skeletal muscle can take several days to weeks, depending 
on the protocol used [15]–[19]. In addition to optimization of freezing medium composition, a 
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comprehensive study of skeletal muscle cryopreservation also requires investigating a proper 
timeline for freezing and reviving engineered tissue. This protocol must take into account the 
maturity of the tissue and the use of undifferentiated myoblasts or differentiated myotubes, and 
yield an understanding of the advantages and disadvantages of freezing tissue in either state. 
Moreover, since all end use applications of engineered skeletal muscle will require the tissue to be 
contractile in response to external stimulation, the effect of cryopreservation on muscle force 
production must also be well characterized. 
This study aims to develop a protocol for freezing and revival of engineered skeletal muscle 
tissue that keeps the tissue viable, metabolically active, and contractile. By providing a deeper 
understanding of the optimized timeline for muscle cryopreservation, this protocol promises to 
generate guidelines for researchers to accomplish long-term storage and revival of skeletal muscle 














CHAPTER 2: METHODOLOGY 
 
2.1 Stereolithographic 3D printing of ring molds and bio-bot skeletons 
Molds for the formation of muscle ‘ring’ structures were 3D printed using a modified form of the 
commercially available stereolithography apparatus (SLA 250/50, 3D Systems), as previously 
reported [15], [16]. These molds were fabricated using 20% w/v PEGDMA of molecular weight 
1000 g mol-1 (Polysciences) with 0.5% w/v Irgacure 2959 (Ciba). We used a biological micro robot 
(biobot) to characterize the forces produced by the muscles [15], [16]. The skeleton of the biobots, 
onto which the muscle rings are transferred, were fabricated using 20% w/v PEGDA of molecular 
weight 700 g mol-1 (Sigma-Aldrich) with 0.5% w/v Irgacure 2959. After fabrication, the parts were 
sterilized in 70% ethanol for 1 hour, followed by storage in phosphate buffered saline (PBS).  
 
2.2 Seeding of C2C12 myoblast rings 
C2C12 murine myoblasts transduced to express Channelrhodopsin-2 (ChR2[H134R]) were 
cultured in growth medium (GM) consisting of Dulbecco’s Modified Eagle Medium with L-
glutamine and sodium pyruvate (DMEM, Corning) supplemented with 10% v/v fetal bovine serum 
(FBS, Lonza), 1% v/v L-glutamine (Cellgro Mediatech), and 1% v/v penicillin-streptomycin 
(Cellgro Mediatech). Upon reaching approximately 85% confluency, cells were trypsinized and 
resuspended at a concentration of 1E7 cells mL-1 within a matrix mixture of 30% v/v Matrigel (BD 
Biosciences), 4 mg mL-1 fibrinogen (Sigma-Aldrich), and 0.5 units mg-fibrinogen-1 thrombin 
(Sigma-Aldrich) in growth medium supplemented with 1 mg mL-1 aminocaproic acid (ACA, 
Sigma-Aldrich) (GM+). The cell-matrix suspension (120 µL) was pipetted into the injection ring 




2.3 Differentiation of skeletal muscle biobots 
C2C12 myoblast rings were cultured for 3 days post-seeding in GM+ (refreshed daily). After 3 
days, the rings were lifted from their molds and transferred to biobot skeletons where they were 
immersed in differentiation medium consisting of DMEM supplemented with 10% v/v heat 
inactivated horse serum (HS, Lonza), 1% v/v L-glutamine, 1% v/v penicillin-streptomycin, 1 mg 
mL-1 ACA, and 50 ng mL-1 human insulin-like growth factor-1 (IGF-1, Sigma Aldrich) (DM++). 
Differentiation medium was refreshed daily for 7 days post ring transfer.   
 
2.4 Freezing and thawing of undifferentiated myoblast rings 
24 hours post-seeding, undifferentiated C2C12 myoblast rings were removed from their molds and 
placed into cryogenic freezing tubes containing 1 mL warm GM supplemented with 10% v/v 
dimethyl sulfoxide (DMSO, Fisher). Freezing tubes were placed in alcohol-free freezing 
containers (CoolCell, Corning) and stored in the -80°C freezer, where they were slowly frozen at 
a rate of 1°C min-1. After 24 hours in the freezer, the cryogenic freezing tubes were placed in a 
warm 37°C water bath for approximately 3 min until completely thawed. The rings were then 
removed from the tubes, rinsed in PBS, and returned to their original ring molds to incubate for 48 
hrs at 37°C. GM+ was refreshed daily. On day 4 post-seeding, rings were transferred to biobot 
skeletons and differentiated for 7 days in DM++.  
 
2.5 Freezing and thawing of differentiated muscle rings 
For this set of experiments, the medium was changed to DM++ on day 3 post-seeding of the cell 
matrix solution on the ring molds. However, muscle rings were left within the ring molds rather 
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than being transferred to biobot skeletons. On day 10 post-seeding, the central portion of the ring 
mold was detached from the rest of the mold, so that the structure could be lifted away with a 
spatula. The central portion of the mold and the surrounding muscle ring was transferred to a 
cryogenic freezing tube containing 1 mL warm GM with 10% v/v DMSO and frozen at -1°C min-
1 to -80°C. After 24 hours in the freezer, the tubes were thawed in a warm 37°C water bath and the 
mold-ring structures were rinsed in PBS. Rings were removed from the molds, transferred to 
biobot skeletons, and returned to culture in DM++ at 37°C.  
 
2.6 MTS viability assay  
MTS solution (CellTiter 96 AQueous One Solution Cell Proliferation Assay, Promega) was 
thawed in a 37°C water bath and combined with warm DMEM (without phenol red) in a 1:5 
volume ratio to form a working reagent. Muscle rings were rinsed in PBS, placed in individual 
wells of a 24 well plate, and immersed in MTS working reagent. The reaction was allowed to 
proceed in the dark for 4 hours at 37°C. A microplate reader (Synergy HT, BioTek) was used to 
measure absorbance at 490 nm, which was then used to calculate relative viability between control 
and experimental samples.   
 
2.7 Passive tension measurement 
Biobots were detached from glass coverslips and placed in a dish of warm, serum-free DMEM. 
Side-view images of the biobots were used to calculate passive tension by applying the Euler-
Bernoulli beam bending theory (Equation 1), as previously described [15].  






Fp is passive tension force, E is the Young’s modulus of the PEGDA skeleton (319.4 kPa), I is the 
moment of inertia of the beam (
1
12
bh3 = 2.77E-14 m4), δmax is the maximum deflection of the beam, 
l is the distance between the muscle and the beam, and L is the length of the beam (6 mm) [15].  
 
2.8 Electrical stimulation and active tension measurement  
Two platinum electrodes were aligned parallel to the biobot to stimulate the muscle with 20 V, 50 
ms pulses at 1 Hz. Videos of biobot muscle contraction were used to calculate active tension 
through motion tracking and application of a Kelvin-Voigt viscoelasticity model (Equation 2) [15]. 
The distance between the two pillars of the biobot was tracked over the course of 150 frames 
(approximately 25 sec depending on frame rate) to calculate strain and determine the time-varying 
force, calculated by equation 2. The peak values of active tension force were averaged, and the 
minimum value of active tension force was subtracted from this average peak value to determine 














Fα is the active tension force, A is the contact area between the muscle ring and the bio-bot 
skeleton, E is the Young’s modulus of the PEGDA skeleton (319.4 kPa), Δy is the change in length 
of the skeleton during a contraction, y0 is the original length of the skeleton in the passive state, η 
is the viscosity of the PEGDA skeleton (5.1 E-3 mPa s), Δε is the change in strain between 
successive frames, and Δt is the time between frames [15].  
 
2.9 RT-qPCR analysis of myogenic marker expression 
Muscle rings were removed from biobot skeletons, rinsed in PBS, and flash-frozen for 5 min in 
liquid nitrogen to be stored at -80°C. Thawed rings were homogenized by vortexing in RLT buffer 
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(Qiagen) with 10 µL mL−1 B-mercaptoethanol and centrifuged using the QIAshredder (Qiagen) 
column. RNA was extracted using the RNeasy Plus RNA isolation kit (Qiagen) according to the 
manufacturer's instructions. cDNA synthesis was done using qScript cDNA SuperMix (Quanta 
Biosciences) from 100 ng of RNA and reactions were performed as directed by the supplier. For 
RT-qPCR, SsoFast EvaGreen Supermix (Bio-Rad) was added to cDNA and primers targeting the 
genes of interest and GAPDH (Table 1, Appendix A). The cycling parameters were 30 s at 95 °C, 
and 40 cycles of 5 s at 95 °C and 20 s at 55 °C, followed by melt-curve analysis of the product 
using a CFX Connect Real-Time System (Bio-Rad). Cycle threshold (Ct) values were used to 
calculate changes in expression level, relative to GAPDH and control samples by the 2 -ΔΔCt 
method [20]. Reaction efficiencies over the appropriate dynamic range were calculated to ensure 
linearity of the standard curve. 
 
2.10 Immunohistochemical staining and light sheet imaging of muscle rings 
Muscle rings to be imaged were rinsed with PBS. To preserve the internal structure, the tissue was 
fixed on the skeleton structures using 4% v/v of paraformaldehyde for 20 minutes. Samples were 
later permeabilized using Triton-X, which was diluted to 0.25% v/v and used to permeabilize the 
tissue membrane for 20 minutes. After washing with PBS, samples were blocked and stored in 1% 
w/v bovine serum albumin (Sigma Aldrich) diluted in PBST at 4 °C.  Cell membrane was 
immunolabeled with mouse anti-myosin heavy chain (MF-20) and rabbit anti-α-actinin, were used 
to stain for myosin and the sarcomere respectively. AlexaFluor-647 anti-mouse (ThermoFisher) 
and AlexaFluor-633 anti-rabbit (ThermoFisher) was used to stain MF-20 and α-actinin primary 
antibodies respectively and incubated for 2 hrs at room temperature.  To be able to image 3D tissue, 
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stained samples were embedded in 1% agarose inside a 1ml syringe. For imaging, the embedded 
sample was suspended in a chamber to be imaged by a Zeiss Z1 Lightsheet microscope. 
 
2.11 Quantifying myotube dispersion 
The Directionality plugin for ImageJ was used to determine the alignment of myotubes through 
Fourier component analysis, as previously demonstrated [21]. A histogram was formed by 
determining the number of myotubes in each direction. A Gaussian fit was calculated from the 
highest peak, which represents the preferred orientation. The standard deviation of the Gaussian 
fit is referred to as the dispersion. The α-actinin fluorescent images were used with the 
Directionality plugin to determine alignment.  
 
2.12 SEM imaging of muscle rings 
Muscle rings were rinsed in PBS and fixed in 4% paraformaldehyde (PFA) for 20 minutes. 
Samples were then rinsed in PBS for 5 minutes, followed by a series of 10 minute immersions in 
37%, 67%, and 95% (x3) ethanol to dehydrate the tissue. Afterwards, samples were washed with 
hexamethyldisilazane and left to dry overnight at room temperature. Samples were then coated 
with gold palladium prior to adhering to a chuck covered with carbon tape. Mounted samples were 
imaged in a FEI Quanta FEG 450 ESEM. 
 
2.13 Statistical Analysis 
In all bar graphs, data is represented as the mean ± standard deviation. The students T test was 




CHAPTER 3: RESULTS 
 
3.1 Freezing of tissue engineered skeletal muscle 
To study the effects of freezing on skeletal muscle, we engineered a versatile ring shaped skeletal 
muscle bioactuator, originally developed by Raman et al. [15], [16]. Skeletal muscle rings were 
formed from a cell-gel mixture of C2C12 myoblasts, fibrin, and Matrigel (Fig 1a) which was added 
to a 3D printed PEGDMA mold (Fig 1b) in order to achieve a ring-like shape. The cell-gel solution 
compacted within the mold over time to form a dense 3D ring structure. After 3 days within the 
mold, the tissue ring was removed from the mold and transferred to a 3D printed PEGDA skeleton 
structure (Fig 1c). The growth medium was changed to a differentiation medium, driving muscle 
ring differentiation over the course of the next 7 days (Fig 1d). After differentiation of the 
myoblasts to myotubes, the biobot was electrically stimulated to observe the contraction of the 
tissue engineered muscle ring. The 3D printed skeleton was designed such that contraction of the 
muscle ring causes deflection of the beam and the inward bending of the two pillars (Fig 1c). The 
bending of the skeleton can be measured in order to quantify the force production of the muscle 






 The engineered muscle ring was frozen at two different time points, before and after 
differentiation, to determine which method would be optimal for preservation of the skeletal 
muscle’s health and function. To cryopreserve the tissue while undifferentiated, the muscle ring 
was frozen after 24 hrs post-cell seeding (Fig 2a). The muscle ring was removed from the ring 
mold and submerged in freezing medium within a cryogenic freezing tube. The ring was found to 
be mechanically robust enough to withstand removal from the mold without rupture. Similarly, 
the tissue maintained its ring-like shape throughout the freezing process and could be easily 
Figure 1. Skeletal muscle bioactuator fabrication. (a) Composition of cell-matrix solution used 
to form the muscle ring. (b) CAD image of 2 ring molds (top) and the skeleton structure 
(bottom) which are 3D printed using stereolithography. The skeleton is printed with its beam 
tethered to the bottom of a glass slide so that the muscle ring remains in tension throughout the 
differentiation process. (c) Side-view image of the mature bioactuator once it has been released 
from the glass slide. (d) On day 0, C2C12 myoblasts and matrix gel components are pipetted 
into a 3D printed PEGDA ring mold. The ring is allowed to solidify and compact in growth 
media for the next 3 days. On day 3, the compacted ring is removed from the mold and 
transferred to a 3D printed, asymmetric skeleton structure and the media is changed to 
differentiation media. On day 10, the skeletal muscle can be placed between two platinum 
electrodes and electrically stimulated to analyze force production of the mature muscle ring. In 
its upright position, the asymmetric design of the skeleton allows for unidirectional locomotion 
of the entire structure. 
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returned to the ring mold post-thaw, where it was allowed to remain in culture for an additional 2 
days before being transferred to the skeleton structure (Fig 2a). The total amount of time in growth 
medium within the ring mold, and in differentiation medium while attached to the skeleton 
structure, was identical to that of an unfrozen muscle ring.  
 The second cryopreservation method involved freezing of the muscle ring after 
differentiation, 9 days post-cell seeding (Fig 2b). This time point of freezing occurs 2 days after 
the skeletal muscle rings first exhibit macroscale contraction, indicating the presence of 
differentiated myotubes [15]. The timeline for muscle differentiation prior to freezing was identical 
to that of the unfrozen ring. However, rather than transferring the ring to the skeleton structure on 
day 3, the ring was left to differentiate within the mold. This was done to avoid having to freeze 
the 3D printed skeleton structure. When the differentiated ring was frozen while attached to the 
skeleton, the entire structure collapsed inward such that the pillars of the skeleton touched and no 
contraction of the ring could be visualized (Fig 3a). The process of freezing likely contributed to 
microstructural changes within the PEGDA that allowed the muscle ring to easily compact the 
weakened structure once it was thawed. To avoid this issue, we attempted to freeze the 
differentiated ring by itself, but found that it could not retain its shape throughout the freezing 
process. The passive tension of the differentiated myotubes caused the ring to compact inward 
such that the ring was too small to be transferred to the skeleton. To avoid these complications, we 
removed the elevated central portion of the ring mold along with the muscle ring in order to 
preserve the shape of the muscle ring throughout the freezing process (Fig 3b,c). After thawing, 
the muscle ring was simply removed from the mold and transferred to the 3D printed skeleton, 







Figure 2. (a) Timeline for freezing of bioactuators before differentiation. 24s hrs post-seeding, 
the ring is removed from culture and placed in a cryogenic freezing vial with 1 mL of medium. 
The ring is slowly frozen at -1 deg C/min and left at -80 deg C for 24 hrs. The ring is rapidly 
thawed for 3 min in a water bath, transferred back to the ring mold, and maintained in culture 
for 24 hrs. On day 4, the ring is transferred to the skeleton and differentiation begins. Evaluation 
of the ring occurs on day 11 (rather than day 10) to account for the “null time” while frozen. 
(b) Timeline for freezing of bioactuators after differentiation. Similar to the standard protocol 
for bioactuator fabrication, differentiation begins on day 3. However, the muscle ring is 
differentiated within the ring mold. The entire central region of the ring mold is frozen with the 
muscle in order to prevent the muscle from losing its shape. After being thawed, the muscle 
ring is transferred directly from the mold to the skeleton and left in culture to recover at least 





3.2 Effect of freezing on cell viability 
To effectively freeze and revive biological tissues without incurring a loss of function, it is 
imperative to prevent significant cell death. In the case of skeletal muscle constructs, a reduction 
in cell number would lead to a decrease in net force production. Furthermore, the presence of dead 
cells may impair the process of myoblast differentiation, thus decreasing the maturity and function 
of single myotubes. In order to examine the effects of freezing on skeletal muscle 3D constructs, 
we began by first freezing muscle rings in the undifferentiated state (1 day post-cell seeding). MTS 
viability assays were performed to optimize the freezing medium composition and quantify the 
effect of the freezing process on cell viability. Undifferentiated muscle rings were frozen in the 
same growth medium (GM) in which they were cultured. Dimethyl sulfoxide, or DMSO, serves 
as a cryoprotectant [22] and was supplemented to the freezing medium at concentrations of 5%, 
10%, and 15% v/v. Muscle rings were slowly frozen at -1 °C/min to -80°C and were thawed rapidly 
after being frozen for 24 hrs. MTS assays showed that undifferentiated muscle rings frozen in 
growth medium with 5% DMSO had a viability of 87% ± 6.5%, rings frozen with 10% DMSO 
Figure 3. (a) Image of differentiated skeletal muscle which was frozen after transfer to the 
PEGDA skeleton. The effects of freezing on the PEGDA skeleton caused deflection of the beam 
such that the pillars came into contact and no active tension could be measured. (b) Image of 
muscle rings differentiated within the ring mold (c) Image demonstrating how the central 
portion of the ring mold is detached from the rest of the mold to be frozen with the muscle ring.  
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had a viability of 93% ± 8.4%, and rings frozen in 15% DMSO had a viability of 84% ± 8.0% (Fig 
4a). Only the rings frozen in 10% DMSO did not exhibit significantly lowered viability as 
compared to the unfrozen control. For this reason, all undifferentiated rings in future studies were 
frozen in growth medium supplemented with 10% DMSO. To examine the effect of total time 
frozen on cell viability, undifferentiated rings were frozen for periods of 1 day, 1 week, 1 month, 
and 2 months. MTS viability assays showed that for all time periods, the viability of frozen rings 
was never significantly lowered, as compared to the unfrozen control (Fig 4b). These results show 
that growth medium supplemented with 10% DMSO serves as an adequate freezing medium for 
undifferentiated muscle rings, which can be frozen for long periods of time without a reduction in 
cell viability.  
While undifferentiated muscle rings could be frozen without a significant effect on cell 
viability, this was not the case for differentiated muscle. When differentiated muscle rings were 
frozen in differentiation medium (DM) with 10% DMSO, viability was significantly reduced to 
73% ± 3.9% (Fig 4c).  To examine whether this effect may have been due to the use of 
differentiation medium rather than growth medium for the freezing process, another viability study 
was conducted to compare differentiated muscle frozen in growth vs differentiation medium (Fig 
4d). Differentiated muscle rings frozen in differentiation medium had a viability of 77% ± 7.7% 
while muscle rings frozen in growth medium had a viability of 81% ± 6.9%. The viability of 
differentiated muscle rings was significantly reduced when frozen in either medium, and no 





3.3 Force production of frozen muscle rings  
To understand how freezing 3D rings of undifferentiated myoblasts impacts their eventual 
development into mature myotubes, we began by measuring their force production post-
differentiation. Differentiated skeletal muscle rings which had previously been frozen for 24 hrs 
in the undifferentiated state surprisingly produced significantly higher active contractile force (174 
± 82 µN) than the unfrozen control (45 ± 17 µN) (Fig 5a) (Video 1-2, Appendix B).  Passive 
tension, however, was not affected by the freezing process (Fig 5b). Active and passive tension of 
a single frozen undifferentiated muscle ring is plotted with time to visualize the change in active 
force production as the muscle contracts under 1 Hz stimulation (Fig 5c). Muscle rings which had 
Figure 4. (a) MTS viability of undifferentiated muscle rings after being frozen for 24 hrs in 
growth medium with varying concentrations of DMSO (n=3). Viability is normalized to that of 
the unfrozen control. (b) MTS viability of undifferentiated muscle rings after being frozen for 
varying time periods in growth media with 10% DMSO (n=3). (c) MTS viability of muscle 
rings frozen after differentiation as compared to muscle rings frozen prior to differentiation 
(mean ± SD, n=3). (d) MTS viability of differentiated muscle rings frozen in differentiation 
media and growth media (n=3). (*p<0.05, **p<0.01) 
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been frozen also contracted spontaneously, while unfrozen rings did not undergo any spontaneous 
contraction (Fig 5d) (Video 3, Appendix B).  
 Skeletal muscle rings which were frozen after differentiation were found to produce 
significantly lower active tension as compared to the unfrozen and frozen differentiated muscle 
(Video 4, Appendix B). When frozen rings were allowed to recover for 24 hrs in culture post-
thawing, only one out of four frozen muscle rings demonstrated macroscale contraction in response 
to stimulation (5.3 µN) (Fig 5e). When these same four muscle rings were allowed to recover in 
culture for another 24 hrs (for a total of 48 hrs post-thaw), all muscle rings increased in active 
tension, by an average of 10 µN (Fig 5e). However, even after 2 days of recovery, average active 
tension of the muscle (11.7±8.5 µN) was still significantly lower than the unfrozen control (Fig 
5a).  Passive tension, however, was not affected by the freezing process (Fig 5b). Freezing medium 
composition was altered in an attempt to maintain higher functional performance of the muscle. 
FBS was increased from 10% to 90%, and DMSO was increased to 20%, but no improvement in 





3.4 Effect of freezing on myogenic marker expression  
To further understand the effects that freezing in the undifferentiated state has on muscle 
development, and to shed light on the molecular mechanisms which may be responsible for the 
observed increase in force production, we used RT-qPCR to analyze the changes in gene 
expression associated with myoblast freezing. The following myogenic markers were measured: 
desmin, myostatin, myogenic factor 5, myogenic factor 6, myosin heavy chain 1, MyoD, 
myogenin, and troponin 1. Differentiated muscle rings which had been frozen for 24 hrs in the 
undifferentiated state showed significantly increased expression of myogenic factor 6 (1.9 ± 0.4 
Figure 5. (a) Active tension produced by differentiated skeletal muscle rings stimulated 
electrically at 1 Hz (n=7,6,5). (b) Passive tension of differentiated skeletal muscle rings 
(n=7,6,5). (c) Active tension (solid line) and passive tension (dotted line) plotted with time for 
a single frozen undifferentiated biobot stimulated at 1 Hz. (d) Electrical and spontaneous active 
tension measurements of three frozen undifferentiated muscle rings. (e) Active tension of 4 
frozen differentiated biobots recovered measured 24 and 48 hrs post-thaw. (f) Freezing media 
for differentiated muscle was modified to increase FBS and DMSO concentration (n=3).  
(*p<0.05, **p<0.01)   
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fold) and myosin heavy chain 1 (1.7 ± 0.3 fold), as compared to the unfrozen control (Fig 6a). 
Myogenic factor 6 (MYF6) is highly expressed in terminally differentiated myotubes or myofibers, 
and upregulation may indicate that the frozen undifferentiated muscle has achieved a more 
advanced state of differentiation [23]. Myosin heavy chain 1 (MYH1) is also a late-stage myogenic 
marker, and is essential for force-generating muscle contraction [24].  
RT-qPCR was also used to evaluate the changes in myogenic marker expression associated 
with the freezing of differentiated muscle. Muscle rings were frozen for 24 hrs in GM with 10% 
DMSO and were recovered in culture for 48 hrs post-thawing. Increased expression of desmin (1.7 
± 0.3 fold), myogenic factor 5 (1.5 ± 0.1 fold), MyoD (2.5 ± 0.7 fold), and myogenin (2.0 ± 0.1 
fold) was observed, while MYF6 showed decreased expression (0.5 ± 0.1 fold), as compared to 
the unfrozen control (Fig 6b).  Increased expression of early stage myogenic markers (MYOD, 
MYF5, and DES) and mid-stage myogenic marker MYOG, together with decreased expression of 
terminal differentiation marker MYF6, could indicate a relative increase in the presence of 
myoblasts as compared to mature myotubes [24]. Compared to the frozen undifferentiated muscle, 
frozen differentiated muscle exhibits significantly higher expression of MYF5, MYOD, and 








3.5 Effect of freezing on myotube structure  
To visualize any changes to myotube structure caused by the freezing process, skeletal muscle 
samples were labeled for α-actinin, myosin, and cell nucleus (DAPI) (Fig 7a-c). Light sheet 
microscopy was used to analyze myotube alignment, thickness, and striation, which all play a 
critical role in the force generation of 3D skeletal muscle tissue [1]. Mature muscle rings which 
had been frozen while undifferentiated showed a dispersion angle of 10.1 ± 2.8° as compared to 
the unfrozen control 9.3 ± 2.1°, indicating no effect of freezing in the undifferentiated state to the 
development of aligned myotubes (Fig 8a). The average myotube width of the frozen 
undifferentiated muscle rings (10.1 ± 0.4 µm) was similar to that of the unfrozen tissue (8.6 ± 1.2 
µm) (Fig 8b). Both the unfrozen and frozen undifferentiated tissues contained visibly striated 
myotubes as indicated by the α-actinin stain, with sarcomere intervals of 1.2 ± 0.02 and 1.2 ± 0.03 
µm, respectively (Fig 8c,d).   
Muscle rings which had been frozen after differentiation, however, had a significantly 
higher dispersion angle of 15.7 ± 6.2. Compared to both the frozen undifferentiated and unfrozen 
Figure 6. (a) RT-qPCR fold change in mRNA expression of various myogenic markers in 
differentiated muscle which had previously been frozen while undifferentiated. Expression is 
normalized to the unfrozen control (mean ± SD, n=3). (b) RT-qPCR fold change in mRNA 
expression in muscle frozen differentiated (mean ± SD, n=3).  (c) Comparison of gene 
expression in frozen undifferentiated and frozen differentiated muscle, each normalized to 
unfrozen controls (mean ± SD, n=3). (*p<0.05, **p<0.01) 
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muscle rings, the increase in dispersion was significantly higher, indicating a disruption to 
myotube alignment caused by the process of freezing differentiated muscle (Fig 8a). The average 
myotube width within the frozen tissue was 8.6 ± 0.8 µm, similar to that of the unfrozen tissue, 
but significantly lower than that of the frozen undifferentiated muscle (Fig 8b). Frozen 
differentiated myotubes also showed striation, with an average sarcomere interval of 1.1 ± 0.12 
µm, similar to that of the unfrozen and frozen undifferentiated tissues, indicating no decrease in 






Figure 7. (a-c) Light sheet images of differentiated skeletal muscle rings stained with a-actinin 





3.6 Effect of freezing on ECM microstructure 
To further understand the mechanism by which the process of freezing undifferentiated muscle 
rings promotes the development of mature muscle with increased force production, we investigated 
the structure of the extracellular matrix. We used SEM to image the surface structure of both 
unfrozen muscle rings and muscle rings which were frozen in the undifferentiated state. Unfrozen, 
undifferentiated samples appeared to have a thick, smooth matrix coating along the surface of the 
ring (Fig 9a), while undifferentiated muscle rings which had been frozen seemed to show an 
apparent thinning of the matrix (Fig 9b). By the time rings which had been frozen in the 
Figure 8. (a) Dispersion angle of myotube directionality shows loss of myotube alignment in 
frozen differentiated muscle (n=12) as compared to unfrozen muscle (n=10) and frozen 
undifferentiated muscle (n=11). (b) Average myotube width obtained by measuring the widest 
diameter of 10 random myotubes within each muscle ring image (mean ± SD, n=3). (c) 
Magnified image of a bundle of myotubes within a frozen undifferentiated muscle ring, 
showing clearly distinguished striation indicated by a-actinin bands. (d) Sarcomere interval 




undifferentiated state were allowed to differentiate, however, their surfaces seemed to be smoother. 
There was no distinguishable difference between the matrices of the frozen vs unfrozen 












Figure 9. SEM images of muscle ring surface. (a) Unfrozen, undifferentiated muscle ring, 
showing appearance of thick ECM coating. (b) Frozen, undifferentiated muscle ring, showing 
apparent thinning of ECM coating as compared to the unfrozen, undifferentiated muscle. (c) 
Unfrozen, differentiated muscle ring.  (d) Differentiated muscle ring which had been previously 
frozen while undifferentiated, showing ECM coating similar in appearance to that of the 
unfrozen, differentiated muscle.  
23 
 
CHAPTER 4: DISCUSSION 
 
Cryopreservation serves as an effective method for the long-term storage of living cells for many 
applications. However, the process of freezing is known to have many detrimental effects on living 
cells. Osmotic intolerance, toxicity of cryoprotectants, chilling or cold-shock, and intracellular ice 
formation can all contribute to cell death or loss of function as cells undergo the freeze-thaw 
process [27]. These negative effects are especially apparent in the freezing of bulk tissues, which 
possess differing heat and mass transfer effects that prevent even temperature and cryoprotectant 
distribution. Our results were consistent in showing the process of freezing to have negligible 
effects on 3D constructs of undifferentiated myoblasts, but a much more detrimental effect when 
freezing occurred after the 3D constructs had been differentiated into a dense skeletal muscle 
tissue.  
The process of cryopreserving differentiated skeletal muscle not only lowered cell 
viability, but also caused a loss of myotube alignment, which likely both contributed to the 
resulting loss of function as demonstrated by the significantly decreased force production [21]. 
Skeletal muscle which had been frozen while differentiated showed increased expression of 
MYOD, which is known to activate in response to cell damage, and can even induce cell apoptosis. 
Desmin is a protein which helps maintain sarcomere alignment and regulate muscle contraction, 
and its increased expression could indicate a defense mechanism as the frozen myotubes attempt 
to maintain alignment, which was disrupted by the freezing process. Even after efforts to alter 
freezing medium composition and allow the muscle rings to recover for up to 48 hrs in medium 
post-thawing, functional performance of the muscle could not be recovered after freezing. For this 
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reason, we do not recommend the cryopreservation of tissue engineered skeletal muscle post-
differentiation.  
 After freezing skeletal muscle constructs while undifferentiated, we were surprised to 
observe an increase in functional performance of the resulting differentiated skeletal muscle. 
Active tension was increased, as was the expression of myosin heavy chain 1, which is integral in 
the process of skeletal muscle contraction. Myogenic factor 6 expression was also increased, 
indicating late stage differentiation as myotubes begin to form myofibers. Myotube alignment was 
maintained, and myotube width was significantly higher than that of the frozen differentiated 
muscle. Overall, there process of freezing skeletal muscle constructs prior to differentiation 
increased muscle performance, and thus, we recommend the protocol indicated in Figure 2a for 
the optimal freezing of tissue engineered skeletal muscle. Using this protocol, tissue engineered 
skeletal muscle rings can be efficiently fabricated in large batches and stored for future use, 
eliminating the time-consuming process of preparing 3D printed molds, expanding C2C12 cell 
cultures, and seeding the cell-gel solution each time a skeletal muscle tissue is needed for 
experimentation. This fabrication efficiency could facilitate the integration of bioactuators into 
laboratory courses to train the next generation of engineers to build systems using biological 
materials [28].  Similarly, skeletal muscle tissue rings could be fabricated by one lab, then frozen 
and shipped to various locations for further applications. Once received, the frozen muscle ring 
would simply need to be thawed and cultured in differentiation medium, making this a simple 
method for laboratories without tissue engineering expertise to integrate skeletal muscle tissues 
within their research. The ability to ship pre-made bioactuators would be instrumental for the 
advancement of skeletal muscle-powered robotics, as many robotics-focused research groups may 
not have the experience or resources required for tissue engineering. Similarly, the efficient 
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fabrication and shipment of large batches of muscle tissues may prove useful in pre-clinical drug 
testing applications, or in future clinical studies in which the tissue engineered skeletal muscle is 
grafted in vivo for the repair of functional muscle [28].    
The goal of this study was to optimize a protocol for the cryopreservation of tissue 
engineered skeletal muscle and characterize the effects of freezing on the muscle. However, the 
surprising discovery that freezing of undifferentiated muscle tissue leads to enhanced functional 
performance of the differentiated muscle may prove to be equally impactful. Currently, tissue 
engineering efforts have not been able to attain the morphology and level of differentiation found 
in native skeletal muscle, resulting in low force generation and little clinical utility [2]. The 
mechanisms by which this freezing-induced enhancement of force generation occurs may lead to 
breakthroughs in the engineering of more highly differentiated and clinically relevant skeletal 
muscle. However, further studies are necessary to determine the exact mechanisms by which the 
freezing-induced changes occur.  
It is known that tissue engineering scaffolds can be tuned in many ways to optimize the 
growth and development of seeded cells. Pore size of the scaffold material, for instance, is known 
to play a critical role in cell attachment and outgrowth, oxygen transfer, and perfusion of nutrients 
and waste [29]. In the case of myoblast differentiation, it has been shown that matrices with 
elongated pores induce the formation of more aligned myotubes capable of higher net force 
production, while also increasing the efficiency of myotube formation [30]. We believe that the 
ice crystal formation associated with the freezing process may have caused changes to the 
microstructure of the tissue’s ECM. The process of freezing ECM has been previously 
demonstrated to increase collagen network pore size, in addition to increasing fibril diameter [31]. 
An increase in porosity of the ECM of frozen undifferentiated muscle may have enabled the more 
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efficient cell migration and fusion, leading to the formation of a more mature myotubes capable of 
higher force production. The SEM images in Figure 5 indicate a change to the ECM structure 
caused by the freezing of undifferentiated muscle tissue. The observation of a thinned ECM in the 
frozen undifferentiated tissue, which appears to recover in thickness by the time the tissue has 
differentiated, may suggest the frozen undifferentiated muscle was able to secrete its own matrix. 
This increase in ECM secretion may have been stimulated by the freezing-induced increase in pore 
size, which has previously been shown to stimulate the increased ECM secretion of chondrocytes 
[32]. Furthermore, ECM composition is known to affect skeletal muscle force generation, and the 
naturally secreted matrix was likely optimal for the development of stronger muscle tissues [17]. 
However, further studies are needed to confirm this hypothesis and analyze the effects of pore size 
and ECM fibril thickness on muscle differentiation. Similarly, imaging of the microstructure 
throughout the 3D tissue and analysis of ECM composition differences in frozen and unfrozen 













CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS 
 
In this study, we optimized a protocol for the cryopreservation of tissue engineered skeletal muscle 
constructs prior to differentiation. This protocol not only maintains cell viability, myotube 
structure, and alignment, and but also leads to increased force generation as well as the increased 
expression of late-stage myogenic markers. Further studies are needed to determine the 
mechanisms by which the freezing of undifferentiated muscle tissue leads to the differentiation of 
stronger skeletal muscle. Specifically, studies which examine the effects of freezing on ECM and 
role of these ECM changes in myogenesis may advance the engineering of stronger, more efficient 
skeletal muscle. The ability to freeze and ship tissue engineered skeletal muscle, as well as the 
resulting increase in force production, will help drive the advancement of clinical and robotic 
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APPENDIX A: RT-QPCR PRIMER SEQUENCES 
 
 
Target Forward Primer (5’-3’) Reverse Primer (5’-3’) 
GAPDH CATCACCATCTTCCAGGAGCGA GTGGTTCACACCCATCACAAACA 
DES CAGTATGAGACCATCGCGGCTA GCAGGTGTAGGACTGGATCTGG 
MSTN ACAGCCTGAATCCAACTTAGGCA CTCATCGCAGTCAAGCCCAAAG 
MYF5 ATGTAACAGCCCTGTCTGGTCC GAGAGAGGGAAGCTGTGTCCTG 
MYF6 TTCTTGAGGGTGCGGATTTCCT GGGAGTTTGCGTTCCTCTGAAG 
MYH1 TGCAGAGCAAGATTGAGGACGA CCAGCTTCTTCCAGCCTCTCG 
MYOD TCCAACTGCTCTGATGGCATGA CCTCACTGTAGTAGGCGGTGTC 
MYOG CAGTGAATGCAACTCCCACAGC CTCAGTTGGGCATGGTTTCGTC 











Table 1. Primer sequences used for RT-qPCR. 
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APPENDIX B: BIOBOT VIDEOS 
 
Video 1. This supplementary file includes the video “Unfrozen 1 Hz Electrical Stimulation” 
which shows the contraction of an unfrozen biobot under 1 Hz electrical stimulation.  
 
Video 2. This supplementary file includes the video “Frozen Undifferentiated 1 Hz Electrical 
Stimulation” which shows the contraction of a frozen undifferentiated biobot under 1 Hz electrical 
stimulation.  
 
Video 3. This supplementary file includes the video “Frozen Undifferentiated Spontaneous” 
which shows the spontaneous contraction of a frozen undifferentiated biobot with no electrical 
stimulation.  
 
Video 4. This supplementary file includes the video “Frozen Differentiated 1 Hz Electrical 
Stimulation” which shows the contraction of a frozen differentiated biobot under 1 Hz electrical 
stimulation after 2 days recovery post-thaw.  
